Cagney, Daniel N. http://orcid.org/0000-0003-2753-5497
Lamba, Nayan
Montoya, Sofia
Li, Puyao
Besse, Luke
Martin, Allison M.
Brigell, Rachel H.
Catalano, Paul J.
Brown, Paul D.
Leone, Jose P.
Tanguturi, Shyam K.
Haas-Kogan, Daphne A.
Alexander, Brian M.
Lin, Nancy U.
Aizer, Ayal A.
Article History
Received: 25 March 2019
Accepted: 10 April 2019
First Online: 13 April 2019
Compliance with ethical standards
:
: Daniel N. Cagney is a recipient of research support from NH Theraguix. Paul Brown reports personal fees from UpToDate (current) and personal fees as DSMB member Novella Clinical (2016) outside the submitted work. Dr. Leone reports that the institution (University of Iowa) received research funding from Merck. Dr. Leone reports funding from Kazia, Lilly, and Seattle Genetics. Daphne A. Haas-Kogan is advisory board member for Cellworks and reports clinical trial support from Novartis. Dr. Lin reports research grants from Pfizer, Genentech/Roche, Novartis, Seattle Genetics, and consulting fees from Pfizer, Genentech/Roche, Novartis, Seattle Genetics, Daichii, and Puma. Dr Alexander reports personal fees from Foundation Medicine, AbbVie, Schlesinger Associates, Bristol Myers Squibb, Precision Health Economics; grants from Puma, Celgene, Eli Lilly outside the submitted work. Dr. Aizer reports research funding from Varian Medical Systems and consulting fees from Novartis. The remaining authors declare no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.